|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/574 | (2006.01) |
| G01N 33/57488 | (2013.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 31/513 | (2013.01) | ||
| G01N2333/49 | (2013.01) | ||
| A61K 38/179 | (2013.01) | ||
| A61K 31/4745 | (2013.01) | ||
| G01N2800/52 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Patento numeris | 3640643 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19201633.5 |
| Europos patento paraiškos padavimo data | 2017-01-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-04-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-12-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 16305065 | 2016-01-25 | EP |
| (72) |
DREYMANN, Jennifer , FR
PACCARD, Caroline , FR
CHIRON-BLONDEL, Marielle , FR
|
| (73) |
Sanofi ,
54, rue La Boétie, 75008 Paris,
FR
|
| (54) | METHOD FOR PREDICTING THE OUTCOME OF A TREATMENT WITH AFLIBERCEPT OF A PATIENT SUSPECTED TO SUFFER FROM A CANCER BY MEASURING THE LEVEL OF A PLASMA BIOMARKER |
| METHOD FOR PREDICTING THE OUTCOME OF A TREATMENT WITH AFLIBERCEPT OF A PATIENT SUSPECTED TO SUFFER FROM A CANCER BY MEASURING THE LEVEL OF A PLASMA BIOMARKER |